存在Razavi-Ⅰ型子宫动脉-卵巢动脉吻合时子宫动脉栓塞术的栓塞终点选择

The choice of embolism end-point for uterine artery embolization when presence type Razavi-Ⅰ uterine artery-ovarian artery anastomose

目的探讨子宫动脉栓塞(UAE)治疗子宫肌瘤或腺肌瘤在有Razavi-Ⅰ型子宫动脉-卵巢动脉吻合(UA-OAa)时的栓塞终点。方法回顾性分析UAE治疗在栓塞前后子宫动脉造影(UAG)明确显示有UA-OAa的子宫肌瘤或腺肌瘤病例。结果在1056例UAE病例中显示68例共有47侧左卵巢动脉和57侧右卵巢动脉存在Razavi-Ⅰ型UA-OAa。20例左侧子宫动脉和27例右侧子宫动脉达到肌瘤动脉栓塞,而UA-OAa保持。68例UAE全部达到技术成功和临床成功,无肌瘤复发和卵巢衰竭病例。结论对有Razavi-Ⅰ型UA-OAa的病例进行UAE治疗,采用肌瘤动脉栓塞作为血管造影栓塞终点是一种有意义的选择。

Objective To research the angiographic embolism end-point for uterine artery embolisation to treat uterine fibroids or adenomyoma when there were type Razavi-Ⅰ uterus artery and ovary artery anastomosis （UA-OAa）. Methods The digital subjection angiographs of uterine artery before and/or after embolisation who demonstrated definitely to there were UA-OAa were analysed retrospectively. Results The ovarian artery of 68 cases in 1 056 uterine fibroids or adenomyoma cases who treated by uterine artery embolisation were visualized distinctly during uterine artery angiography before and/or after embolization, manifestation as type Razavi- I UA-OAa for all. Of them, ovarian artery visualized in sinister 47 cases and in dexter 57 cases respectively. The fibroids artery embolism were achieved in 20 left and 27 right, and the UA-OAa were still remained. The technique succeed and clinical succeed were accomplished, and no recurrence and no ovaries failure for all 68 cases. Conclusions Fibroids artery embolism can use as a optional angipgraph end-point of UAE for type Razavi-Ⅰ UA-OAa cases.